A meta-analysis of pregnancy-associated thrombophilia concluded that pregnant women with heterozygous factor V Leiden mutation and prothrombin G20210A mutation had an eightfold and sevenfold increase in thrombosis risk, respectively (15). This evidence concerns the gene F2 and thrombophilia.